✦ LIBER ✦

1010 Rofecoxib prevents the reduction in platelets experienced as a result of PEGASYS therapy of chronic hepatitis C: a short term pilot study

✍ Scribed by VANTHIEL, D; GEORGE, M; BALUCH, M; DHILLON, S; LEONE, N; MURPHY, L

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet sparing effect of COX II inhibi

✍ Magdalene M George; S.David Li; Ayse L Mindikoglu; Mehdi H Baluch; Sonu Dhillon; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Lamivudine/interferon combination therap

✍ M. Levrero; G. Stivali; A. Rossini; F. Soccorsi; R. Paffetti; I. Gallo; M.E. Bon 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

311 Longer treatment duration with pegin

✍ J.M. Sánchez-Tapias; M. Diago; P. Escartin; J. Enriquez; R. Moreno; H. La Prince 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

A phase II study of the combination of h

✍ Lurie, Yoav; Hyle, Sandy; Gehlsen, Kurt R. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Levamisole and interferon α-2b as combin

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB